- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-09-0005177

About A N Pharmaceuticals Private Limited
Data last updated:
A N Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 November 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2000PTC108617. Its GSTIN is 07AADCA5123E1Z7 (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹98.5 Lakh. It is led by directors Anil Arora (Managing Director) and Rishabh Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 1/4 Okhla Industrial Area Phase – I, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.77 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.55 Cr (net margin 4.3%) and EBITDA of ₹3.08 Cr (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over five years.
The company is associated with 1 brand: An Pharma. As per MCA filings, the company has open charges of ₹18.62 Cr and satisfied charges of ₹5.15 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it. The company has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.65 Cr; the latest was in February 2019. Its 3 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 2 smaller; the largest is Jayhida Medicare Private Limited with revenue of ₹35.94 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2021, listing 12 overdue payments to 3 micro and small suppliers.
A N Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0005177). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anpharmaceuticals.com.
Company details
Recognitions & Rankings of A N Pharmaceuticals
Contact details
A N Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is anpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF – 1/4 Okhla Industrial Area Phase – I, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of A N Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
A N Pharmaceuticals operates one associated brand: An Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical marketing company with a network in Delhi-NCR and UP. | anpharmaceuticals.com |
Business activity
The main business activity of A N Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of A N Pharmaceuticals Private Limited, buy the company report.
Financials of A N Pharmaceuticals Private Limited
FY 2025 filings availableA N Pharmaceuticals Private Limited reported revenue of ₹35.77 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 2% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.08 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.55 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of A N Pharmaceuticals Private Limited, buy the company report.
Board of directors of A N Pharmaceuticals Private Limited
A N Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Arora Also directs: Aurora Nutraceuticals Private Limited | Managing Director | 22 Nov 2000 | 25 Years 11 Months | Current |
| Rishabh Arora Also directs: Aurora Nutraceuticals Private Limited, Abhishek Synfab Private Limited, Anjani Metals Private Limited and 1 more | Director | 03 Jan 2023 | 3 Years 10 Months | Current |
Peer comparison
A N Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jayhida Medicare Private Limited | ₹35.94 Cr (FY 2025) | 13.0% | Hyderabad, Telangana, India | |||
| A N Pharmaceuticals Private Limitedthis company | ₹35.77 Cr (FY 2025) | ₹1.55 Cr | 4.3% | 2.0% | New Delhi, Delhi, India | |
| Aashish Bio Business Private Limited | ₹35.61 Cr (FY 2025) | 109.0% | Telangana, India | |||
| Rasayan Marketing Private Limited | ₹35.54 Cr (FY 2024) | 6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of A N Pharmaceuticals Private Limited, buy the company report.
Auditor
A N Pharmaceuticals Private Limited is audited by H. L. BANSAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H. L. BANSAL & CO. | FY 2023 | 008563N |
Shareholding
The shareholding of A N Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of A N Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Dec 2024 | 101037768 | Hdfc Bank Limited | ₹8.45 Cr | Open | |
| 03 May 2021 | 100442869 | Hdfc Bank Limited | ₹66.61 Lakh | Open | |
| 04 Jan 2021 | 100428576 | Hdfc Bank Limited | ₹9.5 Cr | Open | |
| 09 Feb 2011 | 10271689 | Ing Vysya Bank Limited | ₹3 Cr | Satisfied | |
| 26 Apr 2006 | 10005614 | Canara Bank | ₹15 Lakh | Satisfied |
To see the full charge records of A N Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
A N Pharmaceuticals Private Limited has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.65 Cr; the latest was in February 2019.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Funding round | ₹2.34 Cr | Investors: Soorajmull Baijnath Industries Pvt Ltd , 3 individuals |
| Dec 2018 | Rights issue | ₹49.3 Lakh | Investors: 2 individuals |
| Apr 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Anil Arora HUF, 2 individuals Seller: 4 individuals |
To see the full deal history of A N Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
A N Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by A N Pharmaceuticals, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed by the company against Agusto Formulations Pvt. Ltd. | Disposed |
| District court, Central, Delhi | Court case (LCA) | Filed against the company by an individual | Disposed |
| District court, South, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of A N Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
A N Pharmaceuticals Private Limited has 6 MSME Form 1 returns on record between 2019 and 2021, listing 12 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Symbiosis Pharmaceuticals Private Limited | |||
| Apco Pharma Limited |
To see the full MSME payment records of A N Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
A N Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCA5123E1Z7 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of A N Pharmaceuticals Private Limited, buy the company report.
Recent activity
A N Pharmaceuticals Private Limited has 8 board changes on record since 2000: 2 appointments and 6 cessations. The latest: Rishabh Arora ceased to be Additional Director on 26 Sep 2023.
15 earlier events are in the company report.
Frequently asked questions
A N Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 November 2000 (26+ years old) and is registered under CIN U24233DL2000PTC108617.
A N Pharmaceuticals has 2 current directors:
- Anil Arora - Managing Director
- Rishabh Arora - Director
The latest financial statements of A N Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of A N Pharmaceuticals is 07AADCA5123E1Z7, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of A N Pharmaceuticals is U24233DL2000PTC108617. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
A N Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it.
A N Pharmaceuticals was incorporated on 22 November 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
A N Pharmaceuticals has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.65 Cr; the latest was in February 2019.
The peers of A N Pharmaceuticals by revenue are Jayhida Medicare Private Limited, Aashish Bio Business Private Limited, Rasayan Marketing Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rishabh Arora ceased to be Additional Director on 26 Sep 2023. Rishabh Arora was appointed as Director on 03 Jan 2023. Amit Jha ceased to be Additional Director on 30 Sep 2019. A N Pharmaceuticals has 8 board changes on record in total.
Yes, A N Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-09-0005177).
A N Pharmaceuticals has 6 MSME Form 1 returns on record between 2019 and 2021, listing 12 overdue payments to 3 micro and small suppliers. The latest return was filed on 03 Oct 2021.

